Hereditary Pyropoikilocytosis

Updated: April 26, 2024

Mail Whatsapp PDF Image

Background

Hereditary Pyropoikilocytosis (HPP) is a rare genetic disorder which damages red blood cells in the body and causes abnormal shape with increased risk of destruction of cells.

HPP is an autosomal recessive disorder inherited from each parent and is the same gene, which is responsible for hereditary elliptocytosis, a type of RBC disorder.

Individuals with HPP those have abnormal shaped and fragile type of red blood cells which are prone to break them apart.

Epidemiology

The disorder can affect individuals of any ethnic or racial background.

HPP is usually seen in individuals of African region, but it is also documented in individuals of European and Arab region.

Individual with HPP has family history of red blood cell disorders thus every third member from the family of patient diagnosed with hereditary elliptocytosis.

Anatomy

Pathophysiology

HPP is a condition develops from mutations in genes that encode proteins which is required for maintaining the structural integrity of red blood cells.

HPP is a condition occurs due to abnormalities in the interaction between RBC membrane proteins on both horizontal and vertical surfaces.

The altered spectrin proteins in HPP cause a weakened membrane which increased the vulnerability of red blood cells to damage and deformation.

Etiology

Hereditary Pyropoikilocytosis is a subtype of hereditary elliptocytosis, and it is caused by mutations seen in α-spectrin (SPTA1) and β-spectrin (SPTB) genes respectively.

Individuals with only one copy of a mutated gene are asymptomatic carriers in nature and thus they are not appearing on their own.

Genetics

Prognostic Factors

The prognosis of HPP is decided by the frequency and severity of hemolysis which is the responsible for breakdown of red blood cells.

Frequent or severe hemolysis can increase the risk of complications like chronic anemia, jaundice, and splenomegaly in individuals.

Clinical History

Many individuals with HPP shows symptoms during infancy or early childhood.

Physical Examination

CBC test

Cardiovascular Examination

Respiratory System Assessment

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Severe cases of HPP may appear immediately after birth or within the first few days from birth.

HPP symptoms can range from mild to severe and those who required immediate medical attention among affected individuals.

Differential Diagnoses

  • Hereditary Elliptocytosis
  • Hereditary Spherocytosis
  • Autoimmune Hemolytic Anemia

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

Cases of Severe anemia or hemolysis are required red blood cell transfusion therapy to restore hemoglobin levels and alleviate symptoms, but they should be administered carefully to prevent iron overload.

Frequent blood transfusions cases should be monitored by medical physician for iron overload which can cause organ damage.

Physicians should suggest folic acid supplementation to support red blood cell production in patients.

Appointments with medical physicians and preventing recurrence of disorder is an ongoing life-long effort.

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

use-of-a-non-pharmacological-approach-for-hereditary-pyropoikilocytosis

Physician and consultants should encourage the patients about good hygiene practices and how to minimize exposure to infectious agents which reduces the risk of hemolysis.

Patient should avoid visiting to extreme temperatures like hot and cold places.

Nutritional counselling plays vital role in recovery process of patient as it promotes the nutritional diet including iron, folate, and vitamin B12 which increase red blood cell production.

Sufficient amount of water and fluids intake on regular basis must be followed by patient during period of recovery which reduces risk of any other complications.

Use of Folic acid supplements in treatment of Hereditary Pyropoikilocytosis

  • Folic acid: It is a cofactor in DNA synthesis and erythropoiesis, and it helps to restores folate and increase the production of new red blood cells in the body. The dose should be taken as per physician advised after consulting the status of physical health.

folic-acid-it-is-a-cofactor-in-dna-synthesis-and-erythropoiesis-and-it-helps-to-restores-folate-and-increase-the-production-of-new-red-blood-cells-in-the-body-the-dose-should-be-taken-as-per-physi

Splenectomy is a surgical procedure in which surgeons remove the spleen of individuals who has severe splenomegaly and recurrent hemolytic episodes.

This surgical procedure is performed under general anesthesia, and it involves the removal of the spleen through an abdominal incision.

use-of-phases-in-managing-hereditary-pyropoikilocytosis

In the initial diagnosis phase, the physician assess symptoms related to HPP which is followed by diagnostic tests, including complete blood count, peripheral blood smear, and other hematological investigations.

In the next phase, supportive care and preventive measures should be carried out to reduce pain and improve the overall health of patients.

The regular follow-up visits with medical physician is required to check the improvement of patients and newly observed complaints along with treatment response.

Medication

Media Gallary

Content loading

Latest Posts

Hereditary Pyropoikilocytosis

Updated : April 26, 2024

Mail Whatsapp PDF Image



Hereditary Pyropoikilocytosis (HPP) is a rare genetic disorder which damages red blood cells in the body and causes abnormal shape with increased risk of destruction of cells.

HPP is an autosomal recessive disorder inherited from each parent and is the same gene, which is responsible for hereditary elliptocytosis, a type of RBC disorder.

Individuals with HPP those have abnormal shaped and fragile type of red blood cells which are prone to break them apart.

The disorder can affect individuals of any ethnic or racial background.

HPP is usually seen in individuals of African region, but it is also documented in individuals of European and Arab region.

Individual with HPP has family history of red blood cell disorders thus every third member from the family of patient diagnosed with hereditary elliptocytosis.

HPP is a condition develops from mutations in genes that encode proteins which is required for maintaining the structural integrity of red blood cells.

HPP is a condition occurs due to abnormalities in the interaction between RBC membrane proteins on both horizontal and vertical surfaces.

The altered spectrin proteins in HPP cause a weakened membrane which increased the vulnerability of red blood cells to damage and deformation.

Hereditary Pyropoikilocytosis is a subtype of hereditary elliptocytosis, and it is caused by mutations seen in α-spectrin (SPTA1) and β-spectrin (SPTB) genes respectively.

Individuals with only one copy of a mutated gene are asymptomatic carriers in nature and thus they are not appearing on their own.

The prognosis of HPP is decided by the frequency and severity of hemolysis which is the responsible for breakdown of red blood cells.

Frequent or severe hemolysis can increase the risk of complications like chronic anemia, jaundice, and splenomegaly in individuals.

Many individuals with HPP shows symptoms during infancy or early childhood.

CBC test

Cardiovascular Examination

Respiratory System Assessment

Severe cases of HPP may appear immediately after birth or within the first few days from birth.

HPP symptoms can range from mild to severe and those who required immediate medical attention among affected individuals.

  • Hereditary Elliptocytosis
  • Hereditary Spherocytosis
  • Autoimmune Hemolytic Anemia

Cases of Severe anemia or hemolysis are required red blood cell transfusion therapy to restore hemoglobin levels and alleviate symptoms, but they should be administered carefully to prevent iron overload.

Frequent blood transfusions cases should be monitored by medical physician for iron overload which can cause organ damage.

Physicians should suggest folic acid supplementation to support red blood cell production in patients.

Appointments with medical physicians and preventing recurrence of disorder is an ongoing life-long effort.

Hematology

Physician and consultants should encourage the patients about good hygiene practices and how to minimize exposure to infectious agents which reduces the risk of hemolysis.

Patient should avoid visiting to extreme temperatures like hot and cold places.

Nutritional counselling plays vital role in recovery process of patient as it promotes the nutritional diet including iron, folate, and vitamin B12 which increase red blood cell production.

Sufficient amount of water and fluids intake on regular basis must be followed by patient during period of recovery which reduces risk of any other complications.

Hematology

  • Folic acid: It is a cofactor in DNA synthesis and erythropoiesis, and it helps to restores folate and increase the production of new red blood cells in the body. The dose should be taken as per physician advised after consulting the status of physical health.

Splenectomy is a surgical procedure in which surgeons remove the spleen of individuals who has severe splenomegaly and recurrent hemolytic episodes.

This surgical procedure is performed under general anesthesia, and it involves the removal of the spleen through an abdominal incision.

Hematology

In the initial diagnosis phase, the physician assess symptoms related to HPP which is followed by diagnostic tests, including complete blood count, peripheral blood smear, and other hematological investigations.

In the next phase, supportive care and preventive measures should be carried out to reduce pain and improve the overall health of patients.

The regular follow-up visits with medical physician is required to check the improvement of patients and newly observed complaints along with treatment response.

Free CME credits

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

Digital Certificate PDF

On course completion, you will receive a full-sized presentation quality digital certificate.

medtigo Simulation

A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

medtigo Points

medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
 
  • Registration with medtigo = 10 points
  • 1 visit to medtigo’s website = 1 point
  • Interacting with medtigo posts (through comments/clinical cases etc.) = 5 points
  • Attempting a game = 1 point
  • Community Forum post/reply = 5 points

    *Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.

All Your Certificates in One Place

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.

Our Certificate Courses